3 unchanged sentences
Exhibit Filing Date
+Added: 10.1* First Amendment to Lease Agreement, dated June 28, 2023, by and between ARE-San Francisco No.
+Added: 19 Owner, LLC and the Registrant
+Added: 10.2 First Amendment to Lease Agreement, dated August 25, 2023, by and between 8800 Technology Forest PL, LLC and the Registrant
+Added: 10.3*† Collaboration and License Agreement, dated September 6, 2023, by and between the Registrant and Seagen Inc.
31.1 Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
9 unchanged sentences
104 Cover Page Interactive Data File (formatted as Inline XBRL and included in exhibit 101) X
+Added: * Registrant has omitted certain schedules pursuant to Item 601(a)(5) of Regulation S-K
+Added: † Registrant has omitted portions of the exhibit as permitted under Item 601(b)(10) of Regulation S-K
‡ The certifications furnished in Exhibits 32.1 hereto are deemed to accompany this Quarterly Report on Form 10-Q and are not deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall they be deemed incorporated by reference into any filing under the Securities Act of the Exchange Act.
1 unchanged sentence
NURIX THERAPEUTICS, INC.
−Removed: July 13, 2023
+Added: October 12, 2023
/s/ A RTHUR T.
2 unchanged sentences
(Principal Executive Officer)
−Removed: July 13, 2023
+Added: October 12, 2023
/s/ H ANS VAN H OUTE
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.